Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CALA

Calithera Biosciences

$9.58

0.175 (1.86%)

11:40
11/16/17
11/16
11:40
11/16/17
11:40
Options
One-day call buyers in Calithera Biosciences »

One-day call buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
CALA

Calithera Biosciences

$16.45

1.05 (6.82%)

17:55
11/11/17
11/11
17:55
11/11/17
17:55
Conference/Events
Calithera Biosciences holds a pharmaceutical update conference call »

Management provides a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

CALA

Calithera Biosciences

$16.45

1.05 (6.82%)

04:55
11/11/17
11/11
04:55
11/11/17
04:55
Conference/Events
Calithera Biosciences holds a pharmaceutical update conference call »

Management provides a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

CALA

Calithera Biosciences

$17.20

-0.7 (-3.91%)

14:17
11/04/17
11/04
14:17
11/04/17
14:17
Conference/Events
Calithera Biosciences holds a pharmaceutical update conference call »

Management provides a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

CALA

Calithera Biosciences

$16.00

-0.1 (-0.62%)

07:37
11/02/17
11/02
07:37
11/02/17
07:37
Earnings
Calithera Biosciences reports Q3 EPS (22c), consensus (22c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

Over a month ago
CALA

Calithera Biosciences

$17.60

-0.15 (-0.85%)

, INCY

Incyte

$115.14

-0.5 (-0.43%)

08:13
10/19/17
10/19
08:13
10/19/17
08:13
Hot Stocks
Calithera reports first patient treated in Phase 1 cohort of INCB01158, Keytruda »

Calithera Biosciences…

CALA

Calithera Biosciences

$17.60

-0.15 (-0.85%)

INCY

Incyte

$115.14

-0.5 (-0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 06

    Nov

  • 08

    Nov

CALA

Calithera Biosciences

$15.85

0.6 (3.93%)

09:27
10/05/17
10/05
09:27
10/05/17
09:27
Initiation
Calithera Biosciences initiated at William Blair »

Calithera Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENTA

Enanta

$43.43

-0.07 (-0.16%)

, ADXS

Advaxis

$3.91

-0.36 (-8.43%)

04:55
09/27/17
09/27
04:55
09/27/17
04:55
Conference/Events
Cantor Fitzgerald to hold a conference »

Global Healthcare…

ENTA

Enanta

$43.43

-0.07 (-0.16%)

ADXS

Advaxis

$3.91

-0.36 (-8.43%)

AWR

American States Water

$50.68

-0.8 (-1.55%)

CDTX

Cidara Therapeutics

$8.05

0.2 (2.55%)

GEMP

Gemphire Therapeutics

$9.60

-0.04 (-0.41%)

ARRY

Array BioPharma

$11.29

-0.03 (-0.27%)

AUPH

Aurinia Pharmaceuticals

$6.11

-0.07 (-1.13%)

NEOS

Neos Therapeutics

$8.40

-0.3 (-3.45%)

SELB

Selecta Biosciences

$18.66

-0.18 (-0.96%)

PTGX

Protagonist Therapeutics

$16.28

-0.11 (-0.67%)

ITCI

Intra-Cellular

$19.23

-0.57 (-2.88%)

BLCM

Bellicum Pharmaceuticals

$11.54

-0.08 (-0.69%)

CALA

Calithera Biosciences

$15.45

-0.5 (-3.13%)

INO

Inovio

$6.31

0.02 (0.32%)

PRTA

Prothena

$63.73

-0.64 (-0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 27

    Sep

  • 04

    Oct

  • 05

    Oct

  • 30

    Jun

  • 30

    Jun

  • 28

    Sep

ENTA

Enanta

$43.50

0.79 (1.85%)

, ADXS

Advaxis

$4.27

-0.3 (-6.56%)

04:55
09/26/17
09/26
04:55
09/26/17
04:55
Conference/Events
Cantor Fitzgerald to hold a conference »

Global Healthcare…

ENTA

Enanta

$43.50

0.79 (1.85%)

ADXS

Advaxis

$4.27

-0.3 (-6.56%)

AWR

American States Water

$51.48

0.19 (0.37%)

CDTX

Cidara Therapeutics

$7.85

0.25 (3.29%)

GEMP

Gemphire Therapeutics

$9.64

-0.24 (-2.43%)

ARRY

Array BioPharma

AUPH

Aurinia Pharmaceuticals

$6.18

-0.04 (-0.64%)

NEOS

Neos Therapeutics

$8.70

-0.15 (-1.69%)

SELB

Selecta Biosciences

$18.84

-0.33 (-1.72%)

PTGX

Protagonist Therapeutics

$16.39

-0.46 (-2.73%)

ITCI

Intra-Cellular

$19.80

0.51 (2.64%)

BLCM

Bellicum Pharmaceuticals

$11.62

0.21 (1.84%)

CALA

Calithera Biosciences

$15.95

0.05 (0.31%)

INO

Inovio

$6.29

0.14 (2.28%)

PRTA

Prothena

$64.37

-0.39 (-0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 04

    Oct

  • 05

    Oct

  • 30

    Jun

  • 30

    Jun

ENTA

Enanta

$42.71

-1.14 (-2.60%)

, ADXS

Advaxis

$4.57

-0.16 (-3.38%)

08:28
09/25/17
09/25
08:28
09/25/17
08:28
Conference/Events
Cantor Fitzgerald to hold a conference »

Global Healthcare…

ENTA

Enanta

$42.71

-1.14 (-2.60%)

ADXS

Advaxis

$4.57

-0.16 (-3.38%)

AWR

American States Water

$51.29

0.14 (0.27%)

CDTX

Cidara Therapeutics

$7.60

0.45 (6.29%)

GEMP

Gemphire Therapeutics

$9.88

-0.36 (-3.52%)

ARRY

Array BioPharma

$11.32

-0.15 (-1.31%)

AUPH

Aurinia Pharmaceuticals

$6.22

-0.03 (-0.48%)

NEOS

Neos Therapeutics

$8.85

-0.1 (-1.12%)

SELB

Selecta Biosciences

$19.17

-0.57 (-2.89%)

PTGX

Protagonist Therapeutics

$16.85

-0.28 (-1.63%)

ITCI

Intra-Cellular

$19.29

0.04 (0.21%)

BLCM

Bellicum Pharmaceuticals

$11.41

0.12 (1.06%)

CALA

Calithera Biosciences

$15.90

-0.3 (-1.85%)

INO

Inovio

$6.15

-0.14 (-2.23%)

PRTA

Prothena

$64.76

-0.29 (-0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 04

    Oct

  • 05

    Oct

  • 30

    Jun

  • 30

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.